Etalocib
Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase.
Product Specifications
CAS Number
161172-51-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
544.6
Molecular Formula
C33H33FO6
Notes
Research use only, not for human use.
Receptor
Apoptosis|LTB4
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
